Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 2 trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 3 Country / region: Portugal Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20052
20062
20071
20082
20093
20105
20111
20121
20132
20141
20152
20161
20173
20182
20191
20201
20211
20223
20231
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Terminated9
Recruiting3
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S13
Boehringer Ingelheim7
AstraZeneca5
Sanofi3
Bayer2
Ixaka Ltd2
Lexicon Pharmaceuticals2
Eli Lilly and Company1
Hoffmann-La Roche1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 241
Diabetes Mellitus10
Cardiovascular Diseases5
Obesity4
Chronic Limb-Threatening Ischemia2
Diabetes Mellitus, Type 12
Diabetic Nephropathies2
Heart Failure2
Kidney Diseases2
Peripheral Arterial Disease2

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.